Cohort (CHRT) - Net Assets
Based on the latest financial reports, Cohort (CHRT) has net assets worth GBX166.92 Million GBX (≈ $20.31K USD) as of October 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX413.94 Million ≈ $50.37K USD) and total liabilities (GBX247.03 Million ≈ $30.06K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Cohort (CHRT) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX166.92 Million |
| % of Total Assets | 40.32% |
| Annual Growth Rate | 26.57% |
| 5-Year Change | 88.23% |
| 10-Year Change | 126.15% |
| Growth Volatility | 67.76 |
Cohort - Net Assets Trend (2003–2025)
This chart illustrates how Cohort's net assets have evolved over time, based on quarterly financial data. Also explore Cohort balance sheet assets for the complete picture of this company's asset base.
Annual Net Assets for Cohort (2003–2025)
The table below shows the annual net assets of Cohort from 2003 to 2025. For live valuation and market cap data, see Cohort market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-04-30 | GBX160.09 Million ≈ $19.48K |
+45.75% |
| 2024-04-30 | GBX109.84 Million ≈ $13.36K |
+10.08% |
| 2023-04-30 | GBX99.78 Million ≈ $12.14K |
+11.87% |
| 2022-04-30 | GBX89.19 Million ≈ $10.85K |
+4.87% |
| 2021-04-30 | GBX85.05 Million ≈ $10.35K |
+3.99% |
| 2020-04-30 | GBX81.79 Million ≈ $9.95K |
+6.26% |
| 2019-04-30 | GBX76.97 Million ≈ $9.37K |
+1.76% |
| 2018-04-30 | GBX75.64 Million ≈ $9.20K |
+2.24% |
| 2017-04-30 | GBX73.99 Million ≈ $9.00K |
+4.52% |
| 2016-04-30 | GBX70.79 Million ≈ $8.61K |
+12.64% |
| 2015-04-30 | GBX62.85 Million ≈ $7.65K |
+1.04% |
| 2014-04-30 | GBX62.20 Million ≈ $7.57K |
+5.34% |
| 2013-04-30 | GBX59.05 Million ≈ $7.18K |
+13.33% |
| 2012-04-30 | GBX52.10 Million ≈ $6.34K |
+7.97% |
| 2011-04-30 | GBX48.26 Million ≈ $5.87K |
+4.09% |
| 2010-04-30 | GBX46.36 Million ≈ $5.64K |
+4.74% |
| 2009-04-30 | GBX44.26 Million ≈ $5.39K |
+8.37% |
| 2008-04-30 | GBX40.84 Million ≈ $4.97K |
+98.47% |
| 2007-04-30 | GBX20.58 Million ≈ $2.50K |
+130.60% |
| 2006-04-30 | GBX8.92 Million ≈ $1.09K |
+306.19% |
| 2005-04-30 | GBX2.20 Million ≈ $267.31 |
+53.31% |
| 2004-04-30 | GBX1.43 Million ≈ $174.35 |
+59.58% |
| 2003-04-30 | GBX898.00K ≈ $109.26 |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Cohort's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 9234.7% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (April 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | GBX83.73 Million | 52.79% |
| Common Stock | GBX4.67 Million | 2.94% |
| Other Comprehensive Income | GBX4.66 Million | 2.94% |
| Other Components | GBX65.54 Million | 41.32% |
| Total Equity | GBX158.61 Million | 100.00% |
Cohort Competitors by Market Cap
The table below lists competitors of Cohort ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Nictus
JSE:NCS
|
$6.82 Million |
|
FIXEDzone as
PR:FIXED
|
$6.82 Million |
|
Metro Realty Tbk
JK:MTSM
|
$6.82 Million |
|
Cambium Bio Ltd
AU:CMB
|
$6.83 Million |
|
Identi Healthcare Ltd
TA:IDNT
|
$6.82 Million |
|
Sipa Resources Ltd
AU:SRI
|
$6.81 Million |
|
Home Pottery Public Company Limited
BK:HPT
|
$6.81 Million |
|
Kioson Komersial Indonesia Tbk PT
JK:KIOS
|
$6.81 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cohort's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 108,674,000 to 158,606,000, a change of 49,932,000 (45.9%).
- Net income of 19,249,000 contributed positively to equity growth.
- Dividend payments of 6,476,000 reduced retained earnings.
- Share repurchases of 3,998,000 reduced equity.
- New share issuances of 42,193,000 increased equity.
- Other comprehensive income increased equity by 1,804,000.
- Other factors decreased equity by 2,840,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX19.25 Million | +12.14% |
| Dividends Paid | GBX6.48 Million | -4.08% |
| Share Repurchases | GBX4.00 Million | -2.52% |
| Share Issuances | GBX42.19 Million | +26.6% |
| Other Comprehensive Income | GBX1.80 Million | +1.14% |
| Other Changes | GBX-2.84 Million | -1.79% |
| Total Change | GBX- | 45.95% |
Book Value vs Market Value Analysis
This analysis compares Cohort's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 335.68x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 30155.65x to 335.68x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-04-30 | GBX0.04 | GBX1224.00 | x |
| 2004-04-30 | GBX0.06 | GBX1224.00 | x |
| 2005-04-30 | GBX0.14 | GBX1224.00 | x |
| 2006-04-30 | GBX0.53 | GBX1224.00 | x |
| 2007-04-30 | GBX0.74 | GBX1224.00 | x |
| 2008-04-30 | GBX1.15 | GBX1224.00 | x |
| 2009-04-30 | GBX1.08 | GBX1224.00 | x |
| 2010-04-30 | GBX1.14 | GBX1224.00 | x |
| 2011-04-30 | GBX1.19 | GBX1224.00 | x |
| 2012-04-30 | GBX1.29 | GBX1224.00 | x |
| 2013-04-30 | GBX1.45 | GBX1224.00 | x |
| 2014-04-30 | GBX1.52 | GBX1224.00 | x |
| 2015-04-30 | GBX1.33 | GBX1224.00 | x |
| 2016-04-30 | GBX1.57 | GBX1224.00 | x |
| 2017-04-30 | GBX1.71 | GBX1224.00 | x |
| 2018-04-30 | GBX1.78 | GBX1224.00 | x |
| 2019-04-30 | GBX1.73 | GBX1224.00 | x |
| 2020-04-30 | GBX1.84 | GBX1224.00 | x |
| 2021-04-30 | GBX1.92 | GBX1224.00 | x |
| 2022-04-30 | GBX2.05 | GBX1224.00 | x |
| 2023-04-30 | GBX2.38 | GBX1224.00 | x |
| 2024-04-30 | GBX2.68 | GBX1224.00 | x |
| 2025-04-30 | GBX3.65 | GBX1224.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cohort utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 12.14%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.13%
- • Asset Turnover: 0.68x
- • Equity Multiplier: 2.50x
- Recent ROE (12.14%) is below the historical average (14.67%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | 32.74% | 3.82% | 2.45x | 3.50x | GBX204.20K |
| 2004 | 55.97% | 7.17% | 2.61x | 2.99x | GBX658.70K |
| 2005 | 50.25% | 7.65% | 2.62x | 2.51x | GBX884.30K |
| 2006 | 10.30% | 5.16% | 1.49x | 1.34x | GBX26.60K |
| 2007 | 11.03% | 6.59% | 1.28x | 1.31x | GBX211.10K |
| 2008 | 10.97% | 7.85% | 0.88x | 1.60x | GBX395.70K |
| 2009 | 8.49% | 4.90% | 1.13x | 1.53x | GBX-667.20K |
| 2010 | 4.94% | 2.93% | 1.11x | 1.52x | GBX-2.35 Million |
| 2011 | 5.72% | 4.24% | 0.89x | 1.51x | GBX-2.06 Million |
| 2012 | 8.77% | 6.06% | 1.01x | 1.43x | GBX-643.00K |
| 2013 | 14.13% | 11.77% | 0.95x | 1.27x | GBX2.44 Million |
| 2014 | 9.49% | 8.25% | 0.92x | 1.25x | GBX-319.80K |
| 2015 | 10.30% | 5.63% | 0.94x | 1.95x | GBX165.40K |
| 2016 | 11.97% | 6.91% | 0.99x | 1.75x | GBX1.28 Million |
| 2017 | 5.26% | 3.26% | 0.96x | 1.67x | GBX-3.31 Million |
| 2018 | 11.06% | 7.23% | 0.97x | 1.58x | GBX778.10K |
| 2019 | 7.71% | 4.49% | 0.82x | 2.10x | GBX-1.62 Million |
| 2020 | 12.65% | 7.29% | 0.85x | 2.04x | GBX2.00 Million |
| 2021 | 6.89% | 3.81% | 0.75x | 2.41x | GBX-2.47 Million |
| 2022 | 10.96% | 6.68% | 0.68x | 2.42x | GBX805.00K |
| 2023 | 11.70% | 6.22% | 0.87x | 2.17x | GBX1.65 Million |
| 2024 | 14.09% | 7.56% | 0.80x | 2.32x | GBX4.45 Million |
| 2025 | 12.14% | 7.13% | 0.68x | 2.50x | GBX3.39 Million |
Industry Comparison
This section compares Cohort's net assets metrics with peer companies in the Aerospace & Defense industry.
Industry Context
- Industry: Aerospace & Defense
- Average net assets among peers: $1,992,425,363
- Average return on equity (ROE) among peers: 30.07%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cohort (CHRT) | GBX166.92 Million | 32.74% | 1.48x | $6.82 Million |
| Avon Protection PLC (AVON) | $40.63 Million | 43.22% | 1.87x | $6.21 Million |
| BAE Systems plc (BA) | $7.29 Billion | 23.94% | 2.52x | $725.80 Million |
| Chemring Group PLC (CHG) | $418.10 Million | 11.34% | 0.48x | $17.07 Million |
| Qinetiq Group PLC (QQ) | $1.04 Billion | 8.64% | 0.72x | $28.21 Million |
| Rolls-Royce Holdings PLC (RR) | $5.02 Billion | 1.65% | 3.45x | $1.21 Billion |
| Senior PLC (SNR) | $140.93 Million | 10.80% | 1.39x | $14.34 Million |
| Velocity Composites plc (VEL) | $916.00K | 110.92% | 3.95x | $86.47K |
About Cohort
Cohort plc provides various products and services in defense, security, and related markets in the United Kingdom, Germany, Portugal, Australia, North and South America, Asia Pacific, Africa, and other European countries. It operates through Communications and Intelligence; and Sensors and Effectors segments. The company offers chess dynamic, a surveillance and fire control which provides bespoke… Read more